Fusion Pharmaceuticals Inc.
USD21.55
+0.03 (+0.14%)
CEO
John F. Valliant
IPO Date
2020-06-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Open
$21.55
Prev. Close
$21.52
Day Low
$21.48
Day High
$21.58
52W Low
$2.31
52W High
$21.60
Market Cap
$1.83B
Volume
6.08M
| -1.6 |
| 31 Dec 2021 | FY | -3813.7% | -5628.3% | -35.0% | -32.1% | 0.03 | 16.93 | -2.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -26.6% | -25.2% | 0.00 | 19.24 | -3.3 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 48.3% | -23.3% | -0.17 | 15.58 | -163.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 65.0% | -37.1% | 0.00 | 18.91 | -27.3 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 0.0% | 0.0% | 0.00 | 0.00 | -50.7 |
| -6.2 |
| 30 Sept 2023 | Q3 | 48.0% | -860.0% | -9.2% | -6.8% | 0.28 | 11.63 | -2.6 |
| 30 Jun 2023 | Q2 | -2638.2% | -74044.1% | -12.4% | -9.4% | 0.25 | 12.16 | -3.1 |
| 31 Mar 2023 | Q1 | -56603.6% | -86753.6% | -12.1% | -9.1% | 0.25 | 12.73 | -2.1 |
| 31 Dec 2022 | Q4 | -12476.4% | -17583.6% | -15.2% | -11.2% | 0.25 | 11.88 | -1.4 |
| 30 Sept 2022 | Q3 | -9870.5% | -14465.7% | -13.1% | -10.1% | 0.22 | 16.09 | -1.4 |
| 30 Jun 2022 | Q2 | -2018.6% | -3346.1% | -9.6% | -8.4% | 0.08 | 17.89 | -1.4 |
| 31 Mar 2022 | Q1 | 100.0% | -3403.2% | -9.2% | -8.4% | 0.03 | 16.81 | -4.2 |
| 31 Dec 2021 | Q4 | 100.0% | -2901.7% | -7.4% | -6.8% | 0.03 | 16.93 | -2.6 |